Evidence map›Paper›PMID 32881412›Full record

ArticleCancer reports (Hoboken, N.J.)2022

Tackling brain metastases from lung cancer during the COVID-19 pandemic.

Naveen Mummudi, Anil Tibdewal, Tejpal Gupta, Vijay Patil, Kumar Prabhash, Jai Prakash Agarwal

Open access · hybridAbstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Naveen MummudiDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.ORCID 0000-0002-6083-9225
Anil TibdewalDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Tejpal GuptaDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Vijay PatilDepartment of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Kumar PrabhashDepartment of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Jai Prakash AgarwalDepartment of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Homi Bhabha National Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the enormous strain the COVID-19 pandemic has put on healthcare worldwide, appropriate allocation of resources according to priority is of immense importance. As brain metastases are a common presentation in lung cancer, during the pandemic, it potentially can pose a major management challenge to clinicians. In this article, we outline a pragmatic approach that oncologists should consider while managing these patients. The overarching principle is to deliver best, evidence-based treatment without compromising patient care while ensuring the safety of healthcare workers.

Indexed as

Brain NeoplasmsCOVID-19Lung NeoplasmsHumansPandemicsSARS-CoV-2brain metastasesCOVID-19 pandemiclung cancer

Identifiers

PMID32881412
PMCPMC9124513
OpenAlexW3081981822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.